Clinical validation of a new multi-Aspergillus species reverse transcriptase quantitative PCR: a diagnostic...

Area of Science:

• Mycology and Infectious Diseases
• Molecular Diagnostics
• Fungal Pathogenesis

Background:

• Invasive aspergillosis diagnosis is challenging, relying on multiple criteria.
• Standardized Aspergillus real-time quantitative PCR (qPCR) shows promise but lacks a universal assay.
• Current methods struggle to detect diverse Aspergillus species causing invasive disease.

Purpose of the Study:

• To design, optimize, and validate a novel real-time PCR assay for invasive aspergillosis.
• To develop a multi-Aspergillus section-specific assay for broad species detection.
• To improve diagnostic accuracy and patient monitoring for invasive aspergillosis.

Main Methods:

• Developed a reverse-transcriptase qPCR assay utilizing multi-Aspergillus section-specific primers (MAS-RTqPCR).
• Assay designed to detect nucleic acids from six key Aspergillus sections.
• Validated using a diagnostic case-control study with 120 patients and 223 plasma samples.

Main Results:

• Achieved a limit of detection of five copies/reaction with 100% analytical specificity.
• Clinical sensitivity of 0.91 and clinical specificity of 1.00 in patient validation.
• MAS-RTqPCR identified non-A. fumigatus infections and showed superiority in patient monitoring.

Conclusions:

• The developed MAS-RTqPCR assay is a highly sensitive and specific diagnostic tool.
• This assay shows significant promise for diagnosing invasive aspergillosis.
• It offers a valuable method for monitoring PCR-positive patients.